[Mixed connective tissue disease].
Kondo
Hirobumi
H
Department of Internal Medicine, Kitasato University School of Medicine.
Sakai
Miho
M
D000893:Anti-Inflammatory Agents / Q000627:therapeutic use; D004487:Edema / Q000209:etiology; D005121:Extremities; D006801:Humans; D006976:Hypertension, Pulmonary / Q000209:etiology / Q000628:therapy; D008019:Life Style; D008947:Mixed Connective Tissue Disease / Q000175:diagnosis / Q000209:etiology / Q000628:therapy; D010102:Oxygen Inhalation Therapy; D011379:Prognosis; D012015:Reference Standards; D017412:Ribonucleoprotein, U1 Small Nuclear / Q000276:immunology*; D014665:Vasodilator Agents / Q000627:therapeutic use
D000893:Anti-Inflammatory Agents; D017412:Ribonucleoprotein, U1 Small Nuclear; D014665:Vasodilator Agents